Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by FOXM1 is a transcriptional activator involved in cell proliferation. Additionally we are shipping FOXM1 Proteins (7) and FOXM1 Kits (1) and many more products for this protein.
Showing 10 out of 91 products:
Dog (Canine) Polyclonal FOXM1 Primary Antibody for WB - ABIN2781166
Laoukili, Alvarez, Meijer, Stahl, Mohammed, Kleij, Heck, Medema: Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. in Molecular and cellular biology 2008
Show all 2 references for ABIN2781166
Human Polyclonal FOXM1 Primary Antibody for WB - ABIN610565
Reeves, Helman, Allison, Israel: Molecular cloning and primary structure of human glial fibrillary acidic protein. in Proceedings of the National Academy of Sciences of the United States of America 1989
Human Polyclonal FOXM1 Primary Antibody for IF (p), IHC (p) - ABIN749138
Liu, Zhang, Mao, Zhang, Zhang: Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia. in Biochemical and biophysical research communications 2014
Results show FOXO3a (show FOXO3 Antibodies) and FOXM1, two transcription factors with antagonistic roles in cancer and DNA damage response, mediating signaling and repair as well as for senescence, cell cycle and cell death control. [review]
FOXM1 was a direct target gene of miR (show MLXIP Antibodies)-204, and miR (show MLXIP Antibodies)-204 regulated invasion and epithelial-mesenchymal transition in esophageal cancer by acting directly on the 3'UTR (show UTS2R Antibodies) of FOXM1 mRNA and suppressing its protein expression
miR (show MLXIP Antibodies)-370 inhibited cell growth and metastasis in osteosarcoma cells by down-regulation of FOXM1.
Overexpression of FOXM1, XIAP (show XIAP Antibodies), and Survivin (show BIRC5 Antibodies) contributes to the development of drug-resistance and is associated with poor clinical outcome in breast cancer patients.
overexpression of FOXM1 is associated with multiple myeloma.
results demonstrate that AREG (show AREG Antibodies) controls G2/M progression and cytokinesis in keratinocytes via activation of a FoxM1-dependent transcriptional program, suggesting new avenues for treatment of epithelial cancer
co-immunoprecipitation experiments demonstrated that FOXM1 expression is associated with OTUB1 binding but inversely correlates with conjugation to the protein degradation-associated Lys-48-linked ubiquitin-chains.
the FoxM1/Mcl-1 (show MCL1 Antibodies) pathway may overcome cispaltin resistance of gastric cancer and provide a new therapeutic target for the treatment of gastric cancer
FOXM1 is regulated by LPA (show APOA Antibodies) and YAP (show YAP1 Antibodies) oncogenic signaling pathways in high grade serous ovarian cancer
We also found that forkhead box (show FOXO Antibodies) protein 1 (FOXM1)-induced peroxiredoxin 3 (PRDX3 (show PRDX3 Antibodies)) maintains the mitochondrial function, and the FOXM1/PRDX3 (show PRDX3 Antibodies) mitochondrial pathway maintains survival of colon CSCs
EGF (show EGF Antibodies) promotes FoxM1 expression through the ERK (show EPHB2 Antibodies) signal pathway
FoxM1 induction in the pulmonary vasculature was inhibited by a p110gamma (show PIK3CG Antibodies)-selective inhibitor and in Pik3cg (show PIK3CG Antibodies)(-/-) mice after LPS (show TLR4 Antibodies) challenge. Defective vascular repair in Pik3cg (show PIK3CG Antibodies)-/- mice results from impaired FoxM1 expression
we suggest that proper regional decidualization and polyploidy development requires FoxM1 signaling downstream of Hoxa10 (show HOXA10 Antibodies) and cyclin D3 (show CCND3 Antibodies).
FOXM1 and CENPF (show CENPF Antibodies) are master regulators of prostate cancer malignancy, and can serve as drug response markers for antineoplastic drugs efficiency.
Both gain-of-function and loss-of-function TP53 (show TP53 Antibodies) mutations contribute to overexpression of FoxM1 in high-grade serous ovarian cancer.
MicroRNA-802 suppresses breast cancer proliferation through down-regulation of FoxM1.
FoxM1 expression correlates with proliferation, invasion and migration in mouse hepatocellular carcinoma cell lines.
activated FoxM1 increases beta-cell replication while simultaneously enhancing insulin (show INS Antibodies) secretion and improving glucose homeostasis, making FoxM1 an attractive therapeutic target for diabetes.
Data indicate transcription factor Foxm1 as a critical regulator of the quiescence and self-renewal of hematopoietic stem cells (HSCs).
SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene (show RAB1A Antibodies).
the sequence and expression pattern of FoxM1 (fork head box M1) transcription factor in Xenopus laevis embryos are described
Results suggest that FoxM1 functions to link cell division and neuronal differentiation in early Xenopus embryos.
The protein encoded by this gene is a transcriptional activator involved in cell proliferation. The encoded protein is phosphorylated in M phase and regulates the expression of several cell cycle genes, such as cyclin B1 and cyclin D1. Several transcript variants encoding different isoforms have been found for this gene.
forkhead box protein M1
, forkhead box M1
, forkhead box protein M1-like
, Forkhead, drosophila, homolog-like 16
, HNF-3/fork-head homolog 11
, M-phase phosphoprotein 2
, MPM-2 reactive phosphoprotein 2
, forkhead-related protein FKHL16
, hepatocyte nuclear factor 3 forkhead homolog 11
, transcription factor Trident
, winged-helix factor from INS-1 cells
, forkhead homolog 16
, winged-helix transcription factor Trident
, INS-1 winged helix